Patents by Inventor Oluf Kristian Hoejbjerg Hansen

Oluf Kristian Hoejbjerg Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semaglutide in Cardiovascular Conditions
    Publication number: 20190134162
    Abstract: The present invention relates to the GLP-1 receptor agonist semaglutide for use in medicine.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 9, 2019
    Applicant: Novo Nordisk A/S
    Inventor: Oluf Kristian Hoejbjerg Hansen